Every answer was evasive & not very encouraging. Not too positive if they want investors. They don't have a partner nor anything in the talks, so without that, they didn't sound too encouraging. At least not to me.
"The past month has seen profound changes in Adeona's direction," stated James S. Kuo, M.D., M.B.A., Adeona's Chairman and CEO. "Trimesta is an extremely exciting lead candidate with tremendous potential to transform the care of multiple sclerosis patients. In addition, we believe that dietary management of Alzheimer's and mild cognitive impairment patients with Zinthionein™ ZC may represent an important and safe treatment option for a disease that affects tens of millions of people in the U.S. alone. We have discussions underway with potential corporate partners for this and other programs that we believe could represent the most efficient commercialization route."
This is PFE ☝☝☝
Dont take this one off your watch list
you will miss out if you do,!
you guys always think if it goes up theres good news coming and if it goes down bad news is coming.....Quit thinking like sheep.....Aen is very cyclical it goes up in bunches and also goes down ......thats why you place buy points and sell points. I thought you folks would have learn all of this by now!!!!!
DID Any of you see the recent article by Adam F? I mean reallly... he gave the insight to this POS shit scam of a company! LOL>>. STRONG SELL! and I am not Bashing.. Just being REAL.
Zeonthein, their drug which they promised to launch into the market in Q1 is now moved to Q2
Pfizer rumor acquisition asked during CC. CEO was very evasive. I will take that as no one interested in this POS.